Back
Catalyst Pharmaceuticals Stock Price Chart
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
Sign up now to get this report and avoid a high-yield dividend trap - Yours FREE.
Buy
56
CPRX
Catalyst Pharmaceuticals
Last Price:
15.82
Seasonality Move:
34.21%
7 Day Trial
ALL ACCESS PASS
$
7
Buy a stock when it crosses this line on the chart
Here's the line to follow.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.34 | Buy |
| 20-day SMA: | 15.48 | Buy |
| 50-day SMA: | 15.58 | Buy |
| 200-day SMA: | 14.62 | Buy |
| 8-day EMA: | 15.38 | Buy |
| 20-day EMA: | 15.47 | Buy |
| 50-day EMA: | 15.56 | Buy |
| 200-day EMA: | 14.97 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 54.32 | Buy |
| Chaikin Money Flow: | 139290 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.17 - 16.05) | Buy |
| Bollinger Bands (100): | (14.56 - 16.34) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 15.77 while CPRX 8-day simple moving average is 15.34, which is a Buy signal.
- The stock price of CPRX is 15.77 while Catalyst Pharmaceuticals 20-day SMA is 15.48, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day simple moving average is 15.58 while CPRX share price is 15.77, making it a Buy technically.
- CPRX stock price is 15.77 and Catalyst Pharmaceuticals 200-day simple moving average is 14.62, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
56
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Buy
The current Catalyst Pharmaceuticals [CPRX] share price is $15.77. The Score for CPRX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
1.86B
Price in USD:
15.77
Share Volume:
835.74K
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
17.50
52-Week Low:
11.55
Buy
56
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 15.77 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 15.77 while CPRX 8-day exponential moving average is 15.38, which is a Buy signal.
- The stock price of CPRX is 15.77 while Catalyst Pharmaceuticals 20-day EMA is 15.47, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day exponential moving average is 15.56 while CPRX share price is 15.77, making it a Buy technically.
- CPRX stock price is 15.77 and Catalyst Pharmaceuticals 200-day simple moving average is 14.97, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Catalyst Pharmaceuticals is a Sell
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 54.32, which suggest Catalyst Pharmaceuticals is overbought
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (15.17 - 16.05), which suggest Catalyst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (14.56 - 16.34), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.